Barclays »

Kiniksa Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0M 230k 17.54
2023-09-30 $3.0M 176k 17.37
2023-06-30 $2.3M 163k 14.08
2023-03-31 $1.7M 162k 10.76
2022-12-31 $899k 60k 14.98
2022-09-30 $287k 22k 12.85
2022-06-30 $158k 16k 9.65
2022-03-31 $195k 20k 9.92
2021-12-31 $653k 56k 11.76
2021-09-30 $872k 77k 11.39
2021-06-30 $275k 20k 13.89
2021-03-31 $4.7M 256k 18.51
2020-12-31 $12M 681k 17.67
2020-09-30 $4.4M 288k 15.32
2020-06-30 $423k 17k 25.49
2020-03-31 $97k 6.2k 15.58
2019-12-31 $202k 18k 11.07
2019-09-30 $98k 11k 8.57
2019-06-30 $151k 11k 13.58
2019-03-31 $80k 4.4k 18.21
2018-12-31 $86k 3.1k 28.11
2018-09-30 $62k 2.4k 25.51